# Jiangsu Yahong Pharmaceutical Technology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/jiangsu-yahong-pharmaceutical-technology-co

- Industry: Biotechnology
- Headquarters: Shanghai, China
- Website: www.asieris.cn
- Total disclosed funding: $176M
- Latest round: Series D (Nov 11, 2020)
- Investors on record: 27

## About

Founded in 2010 and based in Shanghai, China, Jiangsu Yahong Pharmaceutical Technology Co., Ltd. is a pharmaceutical company that focuses on the research and development of urogenital oncology drugs. In 2018, the company established the Shanghai R&D Center. The company has offices in Beijing and Taizhou. In 2022, the company was listed on the Shanghai Stock Exchange. Its stock code was 688176. Dr. Ke Pan, the founder, chairman and CEO of the company, once founded Hutchison Whampoa (Shanghai) Pharmaceuticals and served as the senior director and senior director of new medicinal chemistry research and patent protection.

The company engages in the research and development of urogenital oncology drugs. Its main products include Vishco APL-1202, Hackway APL-1706 and Xiweita APL-1702, etc. The company's products are used in urinary system diseases and reproductive system diseases.

## Funding rounds

- Series D, Nov 11, 2020, $106M — Qiming Venture Partners, China International Capital Corporation, YF Capital, Homsun Capital, In Capital, V-Capital, Triwise Capital, IFSC, China Highrun Capital Limited, Xiamen C&D Emerging Industry Equity Investment, Gopher Asset Management, Xiamen C&D Emerging Industry Equity Investment, Baopu Capital, Hengxu Capital, Kaitou Hanrun Investment
- Series C, Jun 28, 2020, $41M — Yingke Private Equity, Tigermed, BioTrack Capital, Taizhou Huacheng Medical Investment Group
- Series C, Mar 24, 2020, $14M — Kaitai Capital, Efung Capital, Lapam Capital, Shenzhen Guozhong Venture Capital, Yanyuan Venture Capital
- Series B, Dec 27, 2017, $15M — Kaitai Capital, Phoenix Fund, Lapam Capital, Zhongguancun Development Group
- Series A, Dec 12, 2016 — TF Capital, Varsal Health Care

## Investors

- TF Capital — Series A
- Varsal Health Care — Series A
- Kaitai Capital (https://capitalatlas.ai/funds/kaitai-capital) — Series B, Series C
- Phoenix Fund (https://capitalatlas.ai/funds/phoenix-fund) — Series B
- Lapam Capital (https://capitalatlas.ai/funds/lapam-capital) — Series B, Series C
- Zhongguancun Development Group — Series B
- Efung Capital (https://capitalatlas.ai/funds/efung-capital) — Series C
- Shenzhen Guozhong Venture Capital (https://capitalatlas.ai/funds/shenzhen-guozhong-venture-capital) — Series C
- Yanyuan Venture Capital — Series C
- Yingke Private Equity (https://capitalatlas.ai/funds/yingke-private-equity) — Series C
- Tigermed (https://capitalatlas.ai/funds/tigermed) — Series C
- BioTrack Capital (https://capitalatlas.ai/funds/biotrack-capital) — Series C
- Taizhou Huacheng Medical Investment Group — Series C
- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series D
- China International Capital Corporation (https://capitalatlas.ai/funds/china-international-capital-corporation) — Series D
- YF Capital (https://capitalatlas.ai/funds/yf-capital) — Series D
- Homsun Capital (https://capitalatlas.ai/funds/homsun-capital) — Series D
- In Capital — Series D
- V-Capital (https://capitalatlas.ai/funds/v-capital) — Series D
- Triwise Capital (https://capitalatlas.ai/funds/triwise-capital) — Series D
- IFSC (https://capitalatlas.ai/funds/ifsc) — Series D
- China Highrun Capital Limited (https://capitalatlas.ai/funds/china-highrun-capital-limited) — Series D
- Xiamen C&D Emerging Industry Equity Investment (https://capitalatlas.ai/funds/xiamen-c-d-emerging-industry-equity-investment) — Series D
- Gopher Asset Management (https://capitalatlas.ai/funds/gopher-asset-management) — Series D
- Baopu Capital (https://capitalatlas.ai/funds/baopu-capital) — Series D
- Hengxu Capital (https://capitalatlas.ai/funds/hengxu-capital) — Series D
- Kaitou Hanrun Investment (https://capitalatlas.ai/funds/kaitou-hanrun-investment) — Series D